INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION
- 1 October 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 334 (8668) , 879-882
- https://doi.org/10.1016/s0140-6736(89)91548-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patientsBritish Journal of Cancer, 1988
- Idiotypes and anti‐idiotypes in myelomaHematological Oncology, 1988
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- The concept of primingEuropean Journal of Cancer and Clinical Oncology, 1985
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975